Director, See Remarks · GoodRx Holdings, Inc. · GoodRx Holdings, Inc. — Restricted Stock Unit
Side
M
Value
—
Shares
111.0K
Price
—
Executed
Apr 15, 2026
Disclosed
Apr 15, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Apr 15 executedApr 15, 2026 disclosed
GDRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 10.0% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Barnes Wendy Lynn filed this Form 4 reporting a option exercise of GDRX on Apr 15, 2026. It became public on Apr 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, See Remarks
Barnes Wendy Lynncik:0002049585
Issuer
GoodRx Holdings, Inc.cik:0001809519
Revision history · 0
No field has changed since this record was first ingested.
